These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 22553951)
1. Mutation-induced loop opening and energetics for binding of tamiflu to influenza N8 neuraminidase. Kar P; Knecht V J Phys Chem B; 2012 May; 116(21):6137-49. PubMed ID: 22553951 [TBL] [Abstract][Full Text] [Related]
2. Infiltration of water molecules into the oseltamivir-binding site of H274Y neuraminidase mutant causes resistance to oseltamivir. Park JW; Jo WH J Chem Inf Model; 2009 Dec; 49(12):2735-41. PubMed ID: 19957991 [TBL] [Abstract][Full Text] [Related]
3. Theoretical studies on the susceptibility of oseltamivir against variants of 2009 A/H1N1 influenza neuraminidase. Li L; Li Y; Zhang L; Hou T J Chem Inf Model; 2012 Oct; 52(10):2715-29. PubMed ID: 22998323 [TBL] [Abstract][Full Text] [Related]
4. Selective binding of antiinfluenza drugs and their analogues to 'open' and 'closed' conformations of H5N1 neuraminidase. Wang P; Zhang JZ J Phys Chem B; 2010 Oct; 114(40):12958-64. PubMed ID: 20860351 [TBL] [Abstract][Full Text] [Related]
5. Long time scale GPU dynamics reveal the mechanism of drug resistance of the dual mutant I223R/H275Y neuraminidase from H1N1-2009 influenza virus. Woods CJ; Malaisree M; Pattarapongdilok N; Sompornpisut P; Hannongbua S; Mulholland AJ Biochemistry; 2012 May; 51(21):4364-75. PubMed ID: 22574858 [TBL] [Abstract][Full Text] [Related]
6. Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses. Singh A; Soliman ME Drug Des Devel Ther; 2015; 9():4137-54. PubMed ID: 26257512 [TBL] [Abstract][Full Text] [Related]
7. On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA). Mitrasinovic PM Biophys Chem; 2009 Mar; 140(1-3):35-8. PubMed ID: 19117662 [TBL] [Abstract][Full Text] [Related]
8. Comment on "Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV)". Rungrotmongkol T; Malaisree M; Udommaneethanakit T; Hannongbua S Biophys Chem; 2009 Apr; 141(1):131-2; author reply 133. PubMed ID: 19231807 [No Abstract] [Full Text] [Related]
9. Insights into susceptibility of antiviral drugs against the E119G mutant of 2009 influenza A (H1N1) neuraminidase by molecular dynamics simulations and free energy calculations. Pan P; Li L; Li Y; Li D; Hou T Antiviral Res; 2013 Nov; 100(2):356-64. PubMed ID: 24055835 [TBL] [Abstract][Full Text] [Related]
10. Source of oseltamivir resistance in avian influenza H5N1 virus with the H274Y mutation. Malaisree M; Rungrotmongkol T; Nunthaboot N; Aruksakunwong O; Intharathep P; Decha P; Sompornpisut P; Hannongbua S Amino Acids; 2009 Oct; 37(4):725-32. PubMed ID: 19002747 [TBL] [Abstract][Full Text] [Related]
11. Insight into the oseltamivir resistance R292K mutation in H5N1 influenza virus: a molecular docking and molecular dynamics approach. Karthick V; Ramanathan K Cell Biochem Biophys; 2014 Mar; 68(2):291-9. PubMed ID: 23794010 [TBL] [Abstract][Full Text] [Related]
12. H274Y's Effect on Oseltamivir Resistance: What Happens Before the Drug Enters the Binding Site. Yusuf M; Mohamed N; Mohamad S; Janezic D; Damodaran KV; Wahab HA J Chem Inf Model; 2016 Jan; 56(1):82-100. PubMed ID: 26703840 [TBL] [Abstract][Full Text] [Related]
13. Binding pattern of the long acting neuraminidase inhibitor laninamivir towards influenza A subtypes H5N1 and pandemic H1N1. Meeprasert A; Khuntawee W; Kamlungsua K; Nunthaboot N; Rungrotmongkol T; Hannongbua S J Mol Graph Model; 2012 Sep; 38():148-54. PubMed ID: 23079644 [TBL] [Abstract][Full Text] [Related]
14. Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV). Mihajlovic ML; Mitrasinovic PM Biophys Chem; 2008 Aug; 136(2-3):152-8. PubMed ID: 18584938 [TBL] [Abstract][Full Text] [Related]
15. Analysis and assay of oseltamivir-resistant mutants of influenza neuraminidase via direct observation of drug unbinding and rebinding in simulation. Woods CJ; Malaisree M; Long B; McIntosh-Smith S; Mulholland AJ Biochemistry; 2013 Nov; 52(45):8150-64. PubMed ID: 24128064 [TBL] [Abstract][Full Text] [Related]
16. Exploring the cause of oseltamivir resistance against mutant H274Y neuraminidase by molecular simulation approach. Karthick V; Shanthi V; Rajasekaran R; Ramanathan K Appl Biochem Biotechnol; 2012 May; 167(2):237-49. PubMed ID: 22544690 [TBL] [Abstract][Full Text] [Related]
17. Understanding of known drug-target interactions in the catalytic pocket of neuraminidase subtype N1. Malaisree M; Rungrotmongkol T; Decha P; Intharathep P; Aruksakunwong O; Hannongbua S Proteins; 2008 Jun; 71(4):1908-18. PubMed ID: 18175324 [TBL] [Abstract][Full Text] [Related]
18. Computational design of novel, high-affinity neuraminidase inhibitors for H5N1 avian influenza virus. Park JW; Jo WH Eur J Med Chem; 2010 Feb; 45(2):536-41. PubMed ID: 19914748 [TBL] [Abstract][Full Text] [Related]
19. Comment on 'Comment on "Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV)"'. Mitrasinovic PM Biophys Chem; 2011 Mar; 154(2-3):102. PubMed ID: 21316835 [No Abstract] [Full Text] [Related]
20. Dynamic behavior of avian influenza A virus neuraminidase subtype H5N1 in complex with oseltamivir, zanamivir, peramivir, and their phosphonate analogues. Udommaneethanakit T; Rungrotmongkol T; Bren U; Frecer V; Stanislav M J Chem Inf Model; 2009 Oct; 49(10):2323-32. PubMed ID: 19780597 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]